XIFIN Closes 6 Million Venture Round New Funding Positions XIFIN To Aggressively Address Clinical Labs Billing Problems

SAN DIEGO, CA., October 12, 2001 — (BUSINESS WIRE) — The company will use proceeds to strengthen its sales, marketing and installation resources supporting the commercial launch of its Accounts Receivable management offering.

Large billing operations, in particular those in clinical laboratories, are in crisis. Bad debt, delayed payments, staffing costs and regulatory compliance problems are at an all time high. XIFIN, a second-generation application service provider, is taking on these problems with an offering that combines sophisticated information management technology with essential transaction services enabling a virtual outsourcing of the entire business processes.

"Continued investor support during a down-market is further validation of our business model," said Lale White, CEO and founder of XIFIN." With over four years in development and new funding we’re well-positioned to aggressively introduce the first new approach to billing management for clinical laboratories in over 10 years."

Windward Ventures led this round, and was joined by earlier investors, which included Enterprise Partners and Boulder Ventures.

About Windward Ventures
Windward Ventures is a venture capital partnership organized in 1997 providing capital and management assistance to early stage, high growth companies in Southern California.

About Enterprise Partners
Enterprise Partners is a Southern California venture capital firm organized to make investments in privately held early stage and emerging growth companies.

About Boulder Ventures
Boulder Ventures, Limited manages venture capital funds dedicated to helping start-up, early stage and emerging-growth companies in information technology and life sciences.


XIFIN is an innovative software and services company dedicated to optimizing the economics of healthcare. The company's cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making. To learn more, visit, or follow XIFIN on Twitter at!/xifin.


Media Relations

To speak with XIFIN directly, contact Fran DuCharme at 858.436.2939 or complete the form below for assistance.

To speak with our PR firm, contact Julie Sculley at 617.986.5730.